Previous 10 | Next 10 |
2023-07-20 09:00:05 ET Summary Medpace Holdings, a Clinical Research Organisation (CRO), has outperformed in the stock market with a return of 429% in the last five years compared to 62% for SPY. CROs, which develop clinical studies for pharma companies, have benefited from increa...
2023-07-10 10:00:00 ET With market capitalizations ranging from $3.6 billion to $7.2 billion, these four mid-cap stocks offer multi-bagger potential. Doximity (NYSE: DOCS) and Progyny (NASDAQ: PGNY) are home to first-mover advantages -- giving them a head start over their co...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2023 financial results after the market close on Monday, July 24, 2023. The Company will host a conference call the following morning, Tuesday, July 25, 2023, at 9:00 a.m. ET to ...
2023-05-08 14:22:27 ET Summary Medpace is one the largest Clinical Research Organisations in the market, and consistently winning market share. On April 24, Medpace presented its earnings for the first quarter of FY23, showing operative strength in a challenging market environment...
2023-05-02 15:43:45 ET The U.S. Food and Drug Administration (FDA) on Tuesday issued a draft guidance to offer further support for decentralized clinical trials (DCTs) where studies for treatments and medical devices can take place beyond traditional trial sites. DCTs can lower the barr...
2023-04-27 14:33:00 ET IQVIA Holdings ( NYSE: IQV ) and ICON Public Limited ( NASDAQ: ICLR ) led decliners in the contract research space Thursday after the companies reiterated the guidance despite reporting better-than-expected Q1 2023 financials. IQV shares have reach...
2023-04-25 13:30:38 ET Gainers: CXApp ( CXAI ) +82% . Petros Pharmaceuticals ( PTPI ) +49% . LogicMark ( LGMK ) +28% . Apollomics ( APLM ) +23% . The Aaron's Company ( AAN ) +18% . Baudax Bio ( BXRX ) +18% . Predi...
2023-04-25 12:09:03 ET Medpace Holdings, Inc. (MEDP) Q1 2023 Earnings Conference Call April 25, 2023, 09:00 AM ET Company Participants Lauren Morris - IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants ...
2023-04-25 12:08:17 ET The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2023 Q1 earnings call. For further details see: Medpace Holdings, Inc. 2023 Q1 - Results - Earnings Call Presentation
2023-04-25 10:06:07 ET Gainers: Baudax Bio ( BXRX ) +48% . Petros Pharmaceuticals ( PTPI ) +48% . Morphic Holding ( MORF ) +22% . Arrowhead Pharmaceuticals ( ARWR ) +17% . Medpace Holdings ( MEDP ) +17% . Losers: Trac...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...